Could a common supplement boost cancer therapy? new trial tests taurine with immunotherapy for stomach cancer.
NCT ID NCT06128252
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding the supplement taurine to a standard treatment (immunotherapy drug serplulimab plus chemotherapy) can improve outcomes for people with locally advanced stomach or gastroesophageal junction cancer. About 96 adults whose tumors have a specific marker (PD-L1 positive) will be randomly assigned to receive either the taurine combination or the standard treatment alone. The main goal is to see if more tumors completely disappear after treatment with the taurine combination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Drum Tower Hospital, Medical School of Nanjing University
RECRUITINGNanjing, Jiangsu, 210008, China
-
Army Specialty Medical Center of PLA (Daping Hospital)
RECRUITINGChongqing, 400042, China
-
Cancer Hospital Affiliated to Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang Uygur Autonomous Region, 830000, China
-
Fudan University Shanghai Cancer Center (FUSCC)
RECRUITINGShanghai, 200032, China
-
Shaanxi Provincial People's Hospital
RECRUITINGXi'an, Shaanxi, 710068, China
-
Tang-Du Hospital
RECRUITINGXi'an, Shaanxi, 710038, China
-
The First Affiliated Hospital of Army Medical University (Southwest Hospital)
RECRUITINGChongqing, 400038, China
-
The First Affiliated Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110001, China
-
The Second Affilated Hospital Of Xi'an Jiaotong University (Xibei Hospital)
RECRUITINGXi'an, Shaanxi, China
-
The Second Affiliated Hospital of Army Medical University (Xinqiao Hospital)
RECRUITINGChongqing, 400037, China
-
The Third People's Hospital of Chengdu
RECRUITINGChengdu, Sichuan, China
-
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
-
Xi 'an International Medical Center Hospital
RECRUITINGXi'an, Shaanxi, 710100, China
-
Xi'an NO.3 hospital
RECRUITINGXi'an, Shaanxi, China
-
Xi-jing Hospital
RECRUITINGXi'an, Shaanxi, 710032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can surgery for stomach or esophageal cancer cloud the mind?